Publication | Closed Access
Phase 2 5-Arm Trial of Ipilimumab Plus Lung or Liver Stereotactic Radiation for Patients with Advanced Malignancies
23
Citations
0
References
2017
Year
Radiation MedicineOncology5-Arm TrialRadiation TherapyIpilimumab Plus LungLiver Stereotactic RadiationClinical Radiation OncologyMedicineRadiation OncologyLung Cancer
No additional data available for this publication yet. Check back later!